Mentice AB (publ) (STO:MNTC)

Sweden flag Sweden · Delayed Price · Currency is SEK
15.00
-0.35 (-2.28%)
Mar 2, 2026, 11:00 AM CET
-29.91%
Market Cap 431.73M
Revenue (ttm) 284.59M
Net Income (ttm) -32.33M
Shares Out 28.13M
EPS (ttm) -1.15
PE Ratio n/a
Forward PE 146.19
Dividend n/a
Ex-Dividend Date n/a
Volume 160
Average Volume 4,416
Open 14.90
Previous Close 15.35
Day's Range 14.90 - 15.00
52-Week Range 8.50 - 22.90
Beta 0.31
RSI 68.35
Earnings Date Feb 2, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patie... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 128
Stock Exchange Nasdaq Stockholm
Ticker Symbol MNTC
Full Company Profile

Financial Performance

In 2025, Mentice AB's revenue was 284.59 million, a decrease of -2.48% compared to the previous year's 291.81 million. Losses were -32.33 million, 75.5% more than in 2024.

Financial Statements

News

There is no news available yet.